Cellular and Molecular Basis of Sleep Loss Neural Injury in Alzheimer Disease
阿尔茨海默病睡眠缺失神经损伤的细胞和分子基础
基本信息
- 批准号:10373983
- 负责人:
- 金额:$ 73.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAcuteAlzheimer&aposs DiseaseBackBehavioralBiochemicalBrain regionCCAAT-Enhancer-Binding ProteinsCa(2+)-Calmodulin Dependent Protein KinaseCalciumCalmodulinCalpainChronicDeveloped CountriesElderlyEndoplasmic ReticulumEnzymesFeedsGRP78 geneGliosisHippocampus (Brain)HumanImpairmentInjuryInositolMediatingMicroinjectionsModelingModificationMolecularMolecular ChaperonesMusNeuronsPRKR genePathologicPharmacologyPhosphotransferasesPlayRestRisk FactorsRoleSleepSleep DeprivationTauopathiesTestingTherapeuticTransgenic MiceTransgenic OrganismsUnited StatesViral VectorWakefulnessactivating transcription factoreffectiveness testingendoplasmic reticulum stressin vivoin vivo calcium imagingknock-downmouse modelnerve injuryneurobehavioralneuron losspreventprotein kinase Rresponsetau Proteinstau aggregationtau mutationtau phosphorylationtau-1therapeutic target
项目摘要
ABSTRACT
Chronic short sleep (CSS) is common in developed countries and yet is likely to be a key modifier of
Alzheimer disease (AD), the most prevalent tauopathy in older adults. Sleep loss acutely increases tau
in humans and in mice, and we have recently shown that CSS hastens the temporal progression of
tauopathy in the P301S murine model of tauopathy, increasing all aspects of tauopathy, including soluble
tau oligomers, pathologic tau aggregation, gliosis, neuron loss and neurobehavioral impairment. The fact
that all aspects of tauopathy are impacted by sleep loss leads us to hypothesize that CSS targets a key
upstream initiating factor. Hippocampal calcium/calmodulin dependent kinase II (HC CAMKII) neurons
are among some of the most vulnerable neurons in AD and show early tau accumulation. We find that
CSS massively increases calcium transients in HC CAMKII neurons, activates CAMKII and calpain, and
induces uncompensated endoplasmic reticulum stress with loss of molecular chaperone BiP. Our overall
hypothesis is that CSS results in excessive intracellular calcium bursts in HC CAMKII neurons, leading
to sustained CAMKII and calpain activation, pathogenic tau modifications, and chronic uncompensated
endoplasmic reticulum stress with loss of BiP that feeds back positively to perpetuate injury. Here we
propose to critically test the role of each component of our working model in the biochemical, pathological
and behavioral aspects of tauopathy and CSS-hastening of tauopathy in the P301S model. In Aim 1, we
will test the role of CSS-increased calcium and calpain in HC CAMKII neurons in the CSS HC tau changes
by genetically suppressing local HC CAMKII calcium and calpain, while verifying suppressed calcium
transients with in vivo calcium imaging of CAMKII neurons. In Aim 2, using pharmacologic inhibition and
conditional HC transgenic knock down of CAMKII across CSS, we will determine to what role CAMKII
induces CSS-induced HC ER stress and CSS effects on tauopathy, and in Aim 3, we will critically test
the role of CSS-reduced BiP in the temporal progression of tauopathy and CSS effects on tauopathy.
Collectively, the proposed studies will identify important in vivo mechanisms by which CSS hastens the
temporal progression of tauopathy and will substantiate therapeutic avenues to lessen CSS exacerbation
of tauopathy and tauopathy progression in general.
抽象的
慢性短睡眠(CSS)在发达国家很常见,但很可能是
阿尔茨海默氏病(AD),是老年人最普遍的tauopathy。睡眠丧失急性增加tau
在人类和小鼠中,我们最近表明CSS加快了时间的进步
p3auopathy的P301s鼠模型中的tauopathy,增加了tauopathy的所有方面,包括可溶性
tau低聚物,病理学tau聚集,神经胶质病,神经元丧失和神经行为障碍。事实
tauopathy的所有方面都受到睡眠损失的影响,使我们假设CSS针对关键
上游启动因子。海马钙/钙调蛋白依赖激酶II(HC CAMKII)神经元
是AD中最脆弱的神经元中的一些,并显示早期Tau的积累。我们发现
CSS大量增加了HC CAMKII神经元中的钙瞬变,激活Camkii和Calpain,并且
诱导无补偿的内质网应激,并导致分子伴侣BIP的损失。我们的整体
假设是CSS导致HC CaMKII神经元中过度细胞内钙爆发,领先
为了持续CAMKII和钙蛋白酶激活,致病性TAU修饰和慢性无偿
内质网应激,损失BIP,其积极地反馈以使损伤永存。我们在这里
提议批判性地测试我们工作模型的每个组成部分在生化,病理学中的作用
在P301S模型中,Tauopathy和Tauopathy的CSS危机的行为方面。在AIM 1中,我们
将测试CSS钙和钙蛋白酶在CSS HC TAU中的HC CAMKII神经元中的作用
通过遗传抑制局部HC Camkii钙和钙蛋白酶,同时验证抑制钙
带有CAMKII神经元体内钙成像的瞬变。在AIM 2中,使用药理抑制和
有条件的HC转基因在CSS上击倒Camkii,我们将确定CAMKII的作用
诱导CSS诱导的HC ER应力和CSS对Tauopathy的影响,在AIM 3中,我们将进行严格的测试
CSS还原BIP在tauopathy和CSS对tauopathy的影响中的作用。
总的来说,拟议的研究将确定CSS加速的重要体内机制
tauopathy的时间进展,并将证实治疗途径以减轻CSS加剧
一般来说,陶氏病和陶氏病的进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NIRMALA NIRINJINI NAIDOO其他文献
NIRMALA NIRINJINI NAIDOO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NIRMALA NIRINJINI NAIDOO', 18)}}的其他基金
Restoration of proteostasis to address co-occurring conditions in Down Syndrome
恢复蛋白质稳态以解决唐氏综合症的并发病症
- 批准号:
10518555 - 财政年份:2022
- 资助金额:
$ 73.12万 - 项目类别:
Interactions between the immune response and lipid homeostasis in regulating sleep during sickness
免疫反应与脂质稳态之间的相互作用在调节疾病期间的睡眠中
- 批准号:
10634707 - 财政年份:2022
- 资助金额:
$ 73.12万 - 项目类别:
Cellular and Molecular Basis of Sleep Loss Neural Injury in Alzheimer Disease
阿尔茨海默病睡眠缺失神经损伤的细胞和分子基础
- 批准号:
10586062 - 财政年份:2020
- 资助金额:
$ 73.12万 - 项目类别:
Age Impaired ER Homeostasis in Wake-Active Neurons: BiP/Nox2 Crosstalk
唤醒活跃神经元中年龄受损的内质网稳态:BiP/Nox2 串扰
- 批准号:
7906549 - 财政年份:2009
- 资助金额:
$ 73.12万 - 项目类别:
Biomarker for Sleep Loss: A Proteomic Determination
睡眠不足的生物标志物:蛋白质组学测定
- 批准号:
7935427 - 财政年份:2009
- 资助金额:
$ 73.12万 - 项目类别:
Biomarker for Sleep Loss: A Proteomic Determination
睡眠不足的生物标志物:蛋白质组学测定
- 批准号:
7816516 - 财政年份:2009
- 资助金额:
$ 73.12万 - 项目类别:
Age Impaired ER Homeostasis in Wake-Active Neurons: BiP/Nox2 Crosstalk
唤醒活跃神经元中年龄受损的内质网稳态:BiP/Nox2 串扰
- 批准号:
7673713 - 财政年份:2008
- 资助金额:
$ 73.12万 - 项目类别:
Age Impaired ER Homeostasis in Wake-Active Neurons: BiP/Nox2 Crosstalk
唤醒活跃神经元中年龄受损的内质网稳态:BiP/Nox2 串扰
- 批准号:
7513243 - 财政年份:2008
- 资助金额:
$ 73.12万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Cellular and Molecular Basis of Sleep Loss Neural Injury in Alzheimer Disease
阿尔茨海默病睡眠缺失神经损伤的细胞和分子基础
- 批准号:
10586062 - 财政年份:2020
- 资助金额:
$ 73.12万 - 项目类别:
Preclinical assessment of GCPII inhibitors for cognition and tau pathology
GCPII 抑制剂对认知和 tau 病理学的临床前评估
- 批准号:
10541131 - 财政年份:2019
- 资助金额:
$ 73.12万 - 项目类别:
Preclinical assessment of GCPII inhibitors for cognition and tau pathology
GCPII 抑制剂对认知和 tau 病理学的临床前评估
- 批准号:
10321239 - 财政年份:2019
- 资助金额:
$ 73.12万 - 项目类别:
Actin and focal adhesion remodeling as therapeutic targets in cardiovascular disease
肌动蛋白和粘着斑重塑作为心血管疾病的治疗靶点
- 批准号:
9303730 - 财政年份:2017
- 资助金额:
$ 73.12万 - 项目类别:
Mitochondrial Biomarkers of Cardiomyopathy and Cure in Chagas Disease
心肌病的线粒体生物标志物和恰加斯病的治疗
- 批准号:
8666721 - 财政年份:2013
- 资助金额:
$ 73.12万 - 项目类别: